Sweet's syndrome associated with FLT3 inhibition

Riyad N.H. Seervai, Elena Paz Munoz, S. Caleb Freeman, Ronan I. Swords, Kevin P. White, Jesse J. Keller

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)89-92
Number of pages4
JournalJAAD Case Reports
Volume54
DOIs
StatePublished - Dec 2024

Keywords

  • FLT3 kinase inhibitor
  • Sweet's syndrome
  • cutaneous toxicity
  • gilteritinib
  • neutrophilic dermatosis
  • oncodermatology
  • quizartinib

ASJC Scopus subject areas

  • Dermatology

Cite this